Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin α5 Signaling.
暂无分享,去创建一个
K. Junker | F. Roos | D. Prawitt | W. Brenner | J. Thüroff | C. Hampel | T. Haber | E. Jöckel
[1] D. Millerb,et al. Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement , 2016 .
[2] S. Doty,et al. Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in Vivo. , 2014, Journal of cancer therapy.
[3] K. Junker,et al. High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor , 2014, Molecular Cancer.
[4] P. Tamboli,et al. Cadherin-11 in Renal Cell Carcinoma Bone Metastasis , 2014, PloS one.
[5] A. Marx,et al. Circulating fibronectin controls tumor growth. , 2013, Neoplasia.
[6] B. Hemmings,et al. PKB/Akt-dependent regulation of cell motility. , 2013, Journal of the National Cancer Institute.
[7] E. Lengyel,et al. A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer. , 2011, Gynecologic oncology.
[8] Xian Chen,et al. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration. , 2011, Cancer research.
[9] F. Roos,et al. Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN. , 2011, International journal of oncology.
[10] W. Gregory,et al. Skeletal complications and survival in renal cancer patients with bone metastases. , 2011, Bone.
[11] G. Duda,et al. Toward biomimetic materials in bone regeneration: functional behavior of mesenchymal stem cells on a broad spectrum of extracellular matrix components. , 2010, Journal of biomedical materials research. Part A.
[12] C. Rancourt,et al. Ovarian cancer ascites protects from TRAIL-induced cell death through αvβ5 integrin-mediated focal adhesion kinase and Akt activation , 2010, Oncogene.
[13] D. Livant,et al. Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation , 2010, Clinical & Experimental Metastasis.
[14] S. Rafii,et al. The bone marrow vascular niche: home of HSC differentiation and mobilization. , 2005, Physiology.
[15] Y. Kanemura,et al. Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues , 1998, Clinical & Experimental Metastasis.
[16] C. Damsky,et al. FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.
[17] K. Sekiguchi,et al. Alternatively Spliced EDA Segment Regulates Fibronectin-dependent Cell Cycle Progression and Mitogenic Signal Transduction* , 1999, The Journal of Biological Chemistry.
[18] Tomohiko Maehama,et al. The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.
[19] B F Boyce,et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. , 1996, The Journal of clinical investigation.